Bladder Cancer Weekly

March 01, 2026

Videos

Peer-to-Peer Clinical Conversations

CORE-008 Cohort A First Results on Cretostimogene Grenadenorepvec for BCG-Naive Bladder Cancer - Shane Pearce

Shane Pearce

Shane Pearce presents CORE-008 Cohort A results with Sam Chang.

Subgroup Findings from CREST Trial in High-Risk Bladder Cancer - Gary Steinberg

Gary Steinberg discusses CREST trial subgroup analysis of very high-risk BCG-naive NMIBC.

Beyond the Abstracts

The Impact of Intravesical Instillations on Quality of Life in Patients with Non-Muscle-Invasive Bladder Cancer: A Systematic Review - Beyond the Abstract

Gender-Based Differences in Psychosocial Well-being Among Bladder Cancer Survivors - Beyond the Abstract

Conference Coverage

ASCO GU 2026: Trastuzumab Deruxtecan in Pretreated Patients with HER2-Expressing Bladder Cancer: Final Results from the Bladder Cancer Cohort in Part 1 of DESTINY-PanTumor02

ASCO GU 2026: SWOG-2427: Single Arm Phase II Study of Bladder Preservation with Immunoradiotherapy After a Clinically Meaningful Response to Neoadjuvant Therapy in Patients with MIBC (BRIGHT)

ASCO GU 2026: A Phase II Clinical Trial of Neoadjuvant Sasanlimab and Stereotactic Body Radiation Therapy as an in Situ Vaccine for Cisplatin-Ineligible MIBC: The RAD VACCINE MIBC Clinical Trial

ASCO GU 2026: Patient Experiences with UGN-102 for Recurrence LG-IR-NMIBC: Insights for Shared Decision Making

Articles

Editor Selected Abstracts and Commentaries

Bladder Cancer

Survival Prediction in Patients With Bladder Cancer Undergoing Radical Cystectomy Using a Machine Learning Algorithm: Retrospective Single-Center Study.

Navigating bladder preservation in Bacillus Calmette-Guérin-unresponsive disease: how much risk is too much?

ImmunityBio Completes Enrollment in Pivotal Randomized Trial Evaluating ANKTIVA® Plus BCG Versus BCG Alone in BCG-Naïve Non-Muscle Invasive Bladder Cancer Carcinoma In Situ

Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes.

Surgical Technique and Perioperative and Postoperative Outcomes for Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion Performed with the Hugo RAS Robotic Platform: First Large Case Series by the European Association of Urology Roboti

Perioperative Immune Checkpoint Inhibitors Combined with Radical Cystectomy: A Rapid Systematic Review and Meta-analysis.

Patterns of local therapy following enfortumab vedotin in advanced urothelial carcinoma.

Loss of KDM6A-mediated genomic instability and metabolic reprogramming regulates response to therapeutic perturbations in bladder cancer.

Optimal Management of Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group.

Contemporary Microhematuria Evaluation in Veterans: Cancer Detection and Resource Utilization.

PA- versus urologist-performed flexible cystoscopy: A comparative study.

Implications of hemoglobin, albumin, lymphocyte, platelet (HALP) score as a predictor of neoadjuvant chemotherapy response in bladder cancer patients.

Neoadjuvant Therapy in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer: Recent Progress, Challenges, and Future Directions in the Era of TAR-200 and Enfortumab Vedotin Plus Pembrolizumab.

Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological Outcomes.

Does the Urinary Microbiome Reflect the Bladder-Cancer-Associated Microbiome? Characterizing the Microbiome in Urine and Cancer Tissue in Bladder Cancer - Beyond the Abstract

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC